What is the appropriate evaluation and management of thrombocytopenia in a pregnant patient?

Thrombocytopenia in Pregnancy: Evaluation and Management

Initial Diagnostic Approach

Begin by confirming true thrombocytopenia with a clean venipuncture sample (avoiding heel-stick or contaminated draws) and immediately assess the severity, timing of onset, and presence of bleeding symptoms to guide your differential diagnosis. 1, 2

Severity Stratification and Timing

• Mild thrombocytopenia (100-150 × 10⁹/L): Most commonly gestational thrombocytopenia, typically presents in late second or third trimester 2, 3
• Moderate thrombocytopenia (50-100 × 10⁹/L): Requires differentiation between gestational thrombocytopenia, immune thrombocytopenia (ITP), and early preeclampsia 4, 5
• Severe thrombocytopenia (<50 × 10⁹/L): Demands urgent evaluation for preeclampsia/HELLP syndrome, thrombotic microangiopathy (TMA), acute fatty liver of pregnancy, or severe ITP 1, 3

Essential Initial Laboratory Workup

• Peripheral blood smear: Examine for schistocytes (suggests TMA), large platelets (suggests ITP or gestational thrombocytopenia), or abnormal white cells 4, 5
• Coagulation studies (PT, aPTT, fibrinogen): Normal in gestational thrombocytopenia and ITP; abnormal suggests HELLP, acute fatty liver, or disseminated intravascular coagulation 3, 4
• Liver enzymes (AST, ALT, LDH, bilirubin): Elevated in preeclampsia/HELLP syndrome or acute fatty liver 1, 5
• Blood pressure and urinalysis: Essential to identify hypertensive disorders of pregnancy 2, 3

Targeted Testing Based on Clinical Context

• If schistocytes present: Obtain ADAMTS13 activity and inhibitor levels to distinguish thrombotic thrombocytopenic purpura (TTP) from other TMAs 6, 5
• If autoimmune history or severe thrombocytopenia: Check antinuclear antibodies, antiphospholipid antibodies, HIV, hepatitis C, and consider H. pylori testing 7, 6
• If family history of bleeding or lifelong mild thrombocytopenia: Consider inherited thrombocytopenia syndromes 3, 4

Differential Diagnosis by Clinical Pattern

Gestational Thrombocytopenia (70-80% of cases)

• Platelet count typically 100-150 × 10⁹/L, rarely <70 × 10⁹/L 2, 3
• Develops in late second or third trimester 1, 4
• No maternal or fetal bleeding risk; resolves postpartum 2, 5
• Management: Observation only; no treatment required 2, 3

Preeclampsia/HELLP Syndrome (15-20% of cases)

• Onset typically after 20 weeks gestation 1, 3
• Hypertension (≥140/90 mmHg), proteinuria, elevated liver enzymes, hemolysis 2, 5
• Management: Delivery is definitive treatment; timing depends on gestational age and severity 1, 3
• Platelet transfusion only if active bleeding or platelet count <20 × 10⁹/L with planned delivery 4, 5

Immune Thrombocytopenia (3-5% of cases)

• Can occur at any trimester; often predates pregnancy 7, 1
• Diagnosis of exclusion after ruling out gestational thrombocytopenia and preeclampsia 3, 5
• Treatment threshold: Platelet count <30 × 10⁹/L or any bleeding 7, 1

For pregnant patients with ITP requiring treatment, use either corticosteroids or intravenous immunoglobulin (IVIg) as first-line therapy. 7

ITP Treatment Protocol in Pregnancy

• First-line: Prednisone 0.5-2 mg/kg/day or IVIg 1 g/kg as single dose 7, 1
• For rapid platelet increase (e.g., approaching delivery): Combine IVIg with corticosteroids 7, 5
• If corticosteroids contraindicated: Use IVIg or anti-D immunoglobulin (in Rh-positive, non-splenectomized patients) 7, 1
• Avoid thrombopoietin receptor agonists during pregnancy due to limited safety data, though they may be considered in refractory cases after careful risk-benefit discussion 5, 8

Thrombotic Thrombocytopenic Purpura (Rare but Life-Threatening)

• Presents with thrombocytopenia, microangiopathic hemolytic anemia, fever, neurologic symptoms, renal dysfunction 6, 5
• ADAMTS13 activity <10% with or without inhibitor 6, 4
• Management: Urgent plasma exchange; do not delay for ADAMTS13 results if clinical suspicion high 5
• Pregnancy can trigger TTP through decreased ADAMTS13 activity and increased von Willebrand factor 6

Secondary Causes to Screen For

• HIV-associated: Treat underlying HIV infection first unless life-threatening bleeding 7, 6
• Hepatitis C-associated: Consider antiviral therapy; monitor platelets closely as interferon may worsen thrombocytopenia 7, 6
• H. pylori-associated: Eradication therapy if positive testing 7, 6

Management of Labor and Delivery

Platelet Thresholds for Procedures

• Vaginal delivery without anesthesia: Safe at platelet count ≥50 × 10⁹/L 2, 4
• Cesarean delivery: Target platelet count ≥50 × 10⁹/L 1, 5
• Neuraxial anesthesia (epidural/spinal): Most institutions require ≥70-80 × 10⁹/L, though ACOG suggests ≥70 × 10⁹/L may be acceptable 2, 5

The mode of delivery should be based on obstetric indications, not maternal platelet count alone. 7, 2

Platelet Transfusion Indications

• Active bleeding at any platelet count 1, 4
• Platelet count <20 × 10⁹/L with planned delivery or invasive procedure 5
• Platelet count <50 × 10⁹/L with cesarean delivery or significant bleeding risk 4
• Do not transfuse prophylactically in stable patients with ITP as transfused platelets are rapidly destroyed 7, 1

Fetal and Neonatal Considerations

Maternal ITP and Neonatal Risk

• Maternal IgG antiplatelet antibodies cross the placenta, causing neonatal thrombocytopenia in 10-15% of cases 1, 3
• Neonatal platelet nadir occurs 2-5 days after birth 9, 4
• Neonatal management if platelets <50 × 10⁹/L: IVIg 1 g/kg; avoid platelet transfusion unless active bleeding 9

Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT)

• Typically presents in first pregnancy with severe thrombocytopenia at birth 9, 3
• Requires HPA genotyping of parents and maternal alloantibody testing 9
• High risk of intracranial hemorrhage (10-20% in untreated cases) 9, 4

Critical Pitfalls to Avoid

• Do not assume all thrombocytopenia in pregnancy is gestational: Platelet count <70 × 10⁹/L, onset in first trimester, or presence of symptoms should prompt investigation for other causes 2, 3
• Do not delay delivery in preeclampsia/HELLP syndrome to raise platelet count; delivery is the definitive treatment 1, 5
• Do not give prophylactic platelet transfusions in ITP without bleeding or planned procedure; this increases alloimmunization risk without benefit 7, 1
• Do not miss TTP: Any pregnant patient with thrombocytopenia plus hemolytic anemia and schistocytes requires urgent ADAMTS13 testing and consideration of plasma exchange 6, 5
• Do not perform splenectomy during pregnancy for ITP except in life-threatening refractory cases; defer to second trimester if absolutely necessary 7, 5